ASHWAGANDHA BIO KSM-66
Food supplement declared in France, decision dated 9 July 2026
ASHWAGANDHA BIO KSM-66 (House of Freïa) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Withania somnifera 300 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- House of Freïa
- Food business operator placing the product on the market
- House of Freïa
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 600 mg
- Directions for use
- A avaler avec un grand verre d'eau.
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, High blood pressure, Liver problems, Taking medication, Taking thyroid medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Mood
Declaration 368174, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Withania somnifera (L.) Dunal | Racine | Extrait sec aqueux | 300 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Conserver à l’abri de la lumière, de la chaleur et de l’humidité. Ne se substitue pas à une alimentation variée et équilibrée. Ne pas dépasser la dose journalière recommandée. Il est recommandé de consulter un médecin si vous présentez un trouble de santé. Déconseillé chez les femmes enceintes et allaitantes, ainsi que chez les personnes atteintes de troubles endocriniens, hépatiques ou cardiaques. Ce complément alimentaire est déconseillé aux personnes suivant un traitement ayant une action sur le système nerveux centra. Tenir hors de portée des enfants.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Withania somnifera (L.) Dunal
Read the warning, when it applies and the studies cited
ASHWAGANDHA - WITHANIA SOMNIFERA
Route of administration: Oral
Cautions and warnings
Condition of application: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Sources cited by Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Sources cited by Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Ashwagandha BIO KSM-66® VITAVEA, declared in 2025 : different composition: 3 ingredient(s) added, 0 missing
- Ashwagandha Bio KSM-66® Onatera, declared in 2025 : different composition: 3 ingredient(s) added, 1 missing
- ASHWAGANDHA BIO KSM-66 Onatera, declared in 2024 : different composition: 1 ingredient(s) added, 0 missing
- Ashwagandha bio (KSM-66®) natural elements, declared in 2024 : different composition: 1 ingredient(s) added, 0 missing
- Ashwagandha Bio KSM66 greenwhey, declared in 2024 : different composition: 1 ingredient(s) added, 0 missing
- ASHWAGANDHA BIO KSM-66 ORFITO BIOACTIVE, declared in 2021, earlier declaration, replaced by the 2025 declaration : different composition: 2 ingredient(s) added, 0 missing
Brand : House of Freïa
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ASHWAGANDHA BIO KSM-66 (House of Freïa): composition and regulation”, https://compoatlas.com/en/supplements/products/368174-ashwagandha-bio-ksm-66, updated 15 November 2026.